<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Chenshen Huang - CV</title>
    <style>
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            line-height: 1.8;
            background: linear-gradient(to right, #f5f5f5, #e6e9f0);
            color: #333;
            padding: 20px;
            margin: 0;
        }
        h1 {
            font-size: 2.8em;
            color: #003366;
            text-align: center;
            margin-bottom: 0.5em;
            text-transform: uppercase;
            letter-spacing: 2px;
        }
        h2 {
            font-size: 2em;
            color: #005b96;
            border-bottom: 2px solid #005b96;
            padding-bottom: 5px;
            margin-top: 1.5em;
            text-transform: capitalize;
        }
        p, ul {
            font-size: 1.15em;
        }
        ul {
            list-style-type: disc;
            margin-left: 25px;
        }
        a {
            color: #007acc;
            text-decoration: none;
            font-weight: bold;
        }
        a:hover {
            text-decoration: underline;
        }
        .section-title {
            font-size: 1.5em;
            margin-top: 1em;
            font-weight: bold;
        }
        .publication-author {
            font-weight: bold;
            color: #d9534f;
        }
        .contact-info strong {
            color: #333;
            font-weight: 600;
        }
        section {
            background-color: #ffffff;
            padding: 25px;
            margin-bottom: 25px;
            border-radius: 15px;
            box-shadow: 0 0 15px rgba(0, 0, 0, 0.15);
            transition: transform 0.2s ease-in-out;
        }
        section:hover {
            transform: translateY(-10px);
        }
        .contact-info p {
            margin: 0.5em 0;
        }
        .publication {
            margin-bottom: 1em;
        }
    </style>
</head>
<body>
    <h1>Chenshen Huang, M.D., Ph.D.</h1>

    <section>
        <h2>Contact Information</h2>
        <div class="contact-info">
            <p><strong>Email:</strong> chenshenhuang@126.com</p>
            <p><strong>Phone:</strong> +86-15060000155</p>
            <p><strong>ORCID:</strong> <a href="https://orcid.org/0000-0001-6107-8264" target="_blank">https://orcid.org/0000-0001-6107-8264</a></p>
            <p><strong>ResearchGate:</strong> <a href="https://www.researchgate.net/profile/Chenshen-Huang" target="_blank">https://www.researchgate.net/profile/Chenshen-Huang</a></p>
        </div>
    </section>

    <section>
        <h2>Research Field</h2>
        <ul>
            <li>Tumor Immune Evasion</li>
            <li>Transcriptional Regulation</li>
            <li>Bioinformatics</li>
        </ul>
    </section>

    <section>
        <h2>Personal Statement</h2>
        <p>I am a dedicated researcher specializing in transcriptional regulation and tumor immune evasion. My work spans two complementary areas: leveraging multi-omics data to uncover transcriptional regulatory patterns and identify novel mechanisms and clinical targets, and applying machine learning to define tumor subtypes and discover therapeutic targets in immunity. These efforts converge on exploring how transcriptional regulation drives immune evasion, advancing cancer biology research and enabling innovations in precision medicine.</p>
    </section>

    <section>
        <h2>Affiliation</h2>
        <p>Department of Gastrointestinal Surgery, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou 350001, China.</p>
    </section>

    <section>
        <h2>Education</h2>
        <p><strong>M.D., Ph.D. Surgery (Gastrointestinal Surgery)</strong><br>Tongji University, Shanghai, China<br>September 2018 - July 2022</p>
        <p><strong>B.M., Clinical Medicine</strong><br>Tongji University, Shanghai, China<br>September 2013 - July 2018</p>
    </section>

    <section>
        <h2>Funds</h2>
        <ul>
            <li><strong>Joint Funds for the Innovation of Science and Technology, Fujian Province</strong> (Grant number: 2023Y9299), Ongoing, Principal Investigator.</li>
            <li><strong>National Natural Science Foundation of China</strong> (Grant number: 82073033), Ongoing, Participant.</li>
        </ul>
    </section>

    <section>
        <h2>Publications</h2>
        <div class="publication">
            <p><span class="publication-author">Huang C</span>, Zhu F, Zhang H, Wang N, Huang Q. Identification of S1PR4 as an immune modulator for favorable prognosis in HNSCC through machine learning. iScience. 2023 Aug 19;26(9):107693. (Article) (Co-first and Lead corresponding author, IF = 4.6)</p>
        </div>
        <div class="publication">
            <p>Li S, Zhang N, Zhang H, Yang Z, Cheng Q, Wei K, Zhou M, <span class="publication-author">Huang C</span>. Deciphering the role of LGALS2: insights into tertiary lymphoid structure-associated dendritic cell activation and immunotherapeutic potential in breast cancer patients. Mol Cancer. 2024 Sep 30;23(1):216. (Research Letter) (Lead corresponding author, IF = 27.7)</p>
        </div>
        <div class="publication">
            <p>Zhang N, Zhang H, Li S, Wu W, Luo P, Liu Z, Chen Y, Xia Z, <span class="publication-author">Huang C</span>, Cheng Q. Uncovering the predictive and immunomodulatory potential of transient receptor potential melastatin family-related CCNE1 in pan-cancer. Mol Cancer. 2024 Nov 18;23(1):258. (Research Letter) (Co-corresponding author, IF = 27.7)</p>
        </div>
        <div class="publication">
            <p>Li SY, Zhang N, Zhang H, Wang N, Du YY, Li HN, <span class="publication-author">Huang CS</span>, Li XR. Deciphering the TCF19/miR-199a-5p/SP1/LOXL2 pathway: Implications for breast cancer metastasis and epithelial-mesenchymal transition. Cancer Lett. 2024 Aug 10;597:216995. (Article) (Co-corresponding author, IF = 9.1)</p>
        </div>
        <div class="publication">
            <p><span class="publication-author">Huang C</span>, Wang N, Zhang N, Chen Z, Ni Z, Liu X, Xiong H, Xie H, Lin B, Ge B, Huang Q, Du B. Multi-omics analysis for potential inflammation-related genes involved in tumour immune evasion via extended application of epigenetic data. Open Biol. 2022 Aug;12(8):210375. (Article) (Co-first author, IF = 4.5)</p>
        </div>
        <div class="publication">
            <p><span class="publication-author">Huang C</span>, Zhang N, Xiong H, Wang N, Chen Z, Ni Z, Liu X, Lin B, Ge B, Du B, Huang Q. Multi-Omics Analysis for Transcriptional Regulation of Immune-Related Targets Using Epigenetic Data: A New Research Direction. Front Immunol. 2022 Jan 3;12:741634. (Article) (Co-first author, IF = 5.7)</p>
        </div>
        <div class="publication">
            <p>Ni Z, <span class="publication-author">Huang C</span>, Zhao H, Zhou J, Hu M, Chen Q, Ge B, Huang Q. PLXNC1: A Novel Potential Immune-Related Target for Stomach Adenocarcinoma. Front Cell Dev Biol. 2021 Jul 2;9:662707. (Article) (Co-first author, IF = 4.6)</p>
        </div>
        <div class="publication">
            <p><span class="publication-author">Huang C</span>, Huang R, Chen H, Ni Z, Huang Q, Huang Z, Ge B. Chromatin Accessibility Regulates Gene Expression and Correlates With Tumor-Infiltrating Immune Cells in Gastric Adenocarcinoma. Front Oncol. 2021 Jan 5;10:609940. (Article) (Co-first author, IF = 3.5)</p>
        </div>
        <div class="publication">
            <p><span class="publication-author">Huang C</span>, Wu L, Wang J, Tharakan B, Peng X. Detecting Three-Dimensional Vascular Networks in the Mouse Embryonic Hindbrain. Methods Mol Biol. 2021;2319:87-92. (Book Chapter) (Co-first author)</p>
        </div>
    </section>
</body>
</html>
